权威 · 专业 · 易懂

您的血液健康专属指南

聚合全球前沿的血液病诊疗、研究和科普信息，为广大血液病患者、家属以及关注血液健康的人士提供权威、全面、易懂的一站式参考平台。

开始阅读常见问题

科普文章

血液病基础知识与健康科普

浏览文章

患者空间

关怀指导与康复经验分享

浏览文章

常见问题

血液病热门问题专业解答

查看FAQ

7+

专业文章

3

内容分类

10+

疾病话题

100%

免费阅读

最新文章

查看全部文章 »

血液病科普知识、最新研究进展与患者关怀

The case for prospective <i>MEN1</i> surveillance in the era of sequential menin inhibitor therapy

Leukemia, Published online: 25 June 2026; doi:10.1038/s41375-026-03023-zThe case for prospective MEN1 surveillance in the era of sequential menin inhibitor therapy

Integrated transcriptomic and TCR profiling reveals local immune dysregulation of T cells in Gl aGvHD

Bone Marrow Transplantation, Published online: 25 June 2026; doi:10.1038/s41409-026-02942-wIntegrated transcriptomic and TCR profiling reveals local immune dysregulation of T cells in Gl aGvHD

Long-term follow-up of the transplant-eligible cohort of the EMN12/HOVON-129 study for primary plasma cell leukemia patients

Blood Cancer Journal, Published online: 24 June 2026; doi:10.1038/s41408-026-01549-0Long-term follow-up of the transplant-eligible cohort of the EMN12/HOVON-129 study for primary plasma cell leukemia

CHIP-AML22: a complex clinical trial in de novo pediatric AML patients, including a gemtuzumab ozogamicin randomization and targeted therapy with quizartinib in eligible subgroups, within the NOPHO-DB-SHIP consortium.

The overall survival of children with newly diagnosed acute myeloid leukemia (AML) in high-income countries has increased to 80% over the past decades. Nevertheless, a significant subset of patients e

FAQ